Nova Nordisk (NYSE: NVO) today announced that diabetes patients taking NovoLog(®) (insulin aspart [rDNA origin] injection) can now use the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE